Hyundai Sonata Recall Issued Due to Brake Component Deterioration

More than 300,000 Hyundai Sonata 4-door sedans have been recalled, after the manufacturer received several warranty claims indicating that the brake pedal stopper pad deteriorated prematurely, potentially increasing the risk of an auto accident

The Hyundai Sonata recall (PDF) was announced by the U.S. National Highway Traffic Safety Administration (NHTSA) on November 13, after an investigation found that the brake pedal stopper pad may be prone to deteriorate and fail over time, allowing the vehicle to perform functions that would normally require the brake to be engaged, such as shifting gears and activating the brake pedal override feature.

Hyundai began receiving warranty claims in July 2014, requiring the replacement of the brake pedal stopper pads due to deterioration factors. The automaker serviced several claims and continued to monitor for further complaints.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

By September 2015, Hyundai’s had reached a 0.5 percent claim rate and opened an investigation that is still underway to determine the root cause. No accidents or injuries have been reported.

The recalled Sonata vehicles have a brake pedal stopper pad that is located between the stop lamp switch and the brake pedal arm, which at this time is believed to be made of a material that will deteriorate and pose several safety hazards.

In the event stopper pad material deteriorates, it could cause the stop lamps switch plunger to remain extended when the brake pedal is released, leaving the brake lights  illuminated. The problem can also allow the shifter to be moved out of gear without depressing the brake pedal. In addition the problem could illuminate the traction control warning lamp, and activate the engine management system’s brake pedal override feature.

According to both Hyundai Motors and the NHTSA, any one or combination of these possible outcomes could pose a crash hazard including roll-away hazards and miscommunication of signals to rearward approaching vehicles.

The recall includes 304,000 model year 2011 through 2012 Hyundai Sonata vehicles manufactured by Hyundai Motor America. The specific line of vehicles recalled was manufactured at the Hyundai Motor Manufacturing plant in Alabama from December 11, 2009 through June 2011 and distributed for sale at licensed dealers throughout the U.S.

Hyundai’s investigators are still trying to determine the definitive root cause. However, the company has announced a repair process anticipated to begin in January 2016.

Owners with recalled models will receive notification via mail to schedule an appointment at a licensed local dealer to have the brake pedal stopper pad replaced with an improved part free of charge. Owners with further questions may contact Hyundai Customer Service at 1-855-671-3059 and reference the company recall number 136.

1 Comments

  • JimAugust 24, 2020 at 1:28 pm

    2012 Hyundai Sonata hybrid; constant problems involving loss of power. Try to pass a slow vehicle, best of luck. Sometimes yes, sometimes no. Hybrid system warning lights and chimes, pull over and shut off for a minute, restart and the car runs okay until the next time. Three different dealerships, plus several independent garages, no solutions. No codes, and if the dealer can’t find a code, then [Show More]2012 Hyundai Sonata hybrid; constant problems involving loss of power. Try to pass a slow vehicle, best of luck. Sometimes yes, sometimes no. Hybrid system warning lights and chimes, pull over and shut off for a minute, restart and the car runs okay until the next time. Three different dealerships, plus several independent garages, no solutions. No codes, and if the dealer can’t find a code, then all is supposedly right as rain. Bought this car new and it has never been the same after a dealership service at 80,000 miles. Charged me for cleaning the throttle body, but it had never been taken off the intake manifold, which was discovered when we replaced the throttle body. Mileage improved 25% immediately, but car still stalls and slows down under full throttle. Terribly dangerous and unpredictable. Would love to sell, but don’t wish to make an enemy. POS car! By the way, Hyundai could care less.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.